SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Laboratories informs about newspaper publication

14 Aug 2024 Evaluate

Valiant Laboratories has informed that it enclosed copies of the newspaper publication of the Standalone and Consolidated Audited Financial Results for the quarter ended June 30, 2024, published in newspapers: 1) The Financial Express (in English) and 2) Mumbai Lakshadeep (in Marathi) on August 14, 2024. A copy of the advertisement is also available on the website of the Company at www.valiantlabs.in.

The above information is a part of company’s filings submitted to BSE.


Valiant Laboratories Share Price

67.00 0.30 (0.45%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×